High dose androgen suppresses natural killer cytotoxicity of castration-resistant prostate cancer cells via altering AR/circFKBP5/miRNA-513a-5p/PD-L1 signals

Most advanced prostate cancer (PCa) patients initially respond well to androgen deprivation therapy, but almost all eventually develop castration-resistant prostate cancer (CRPC). Early studies indicated the bipolar androgen therapy via a cycling of high dose and low dose of androgen to suppress PCa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Min, Sun, Yin, Huang, Chi-Ping, Chen, Lei, Liu, Bianjiang, You, Bosen, Wang, Zengjun, Chang, Chawnshang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424293/
https://www.ncbi.nlm.nih.gov/pubmed/36038573
http://dx.doi.org/10.1038/s41419-022-04956-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424293/
https://www.ncbi.nlm.nih.gov/pubmed/36038573
http://dx.doi.org/10.1038/s41419-022-04956-w

Ejemplares similares